SERPINA1 Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
SERPINA1 Peptide Applications :
Blocking Background :
SERPINA1 is secreted and is a serine protease inhibitor which its targets include elastase, plasmin, collagenase, thrombin, leucocytic proteases, trypsin, chymotrypsin, and plasminogen activator. Defects in SERPINA1 gene can cause emphysema or liver disease. Antral SERPINA1 expression is particularly induced by H. pylori infection. lung and prostate cancers have shown a significant increase in SERPINA1 serum levels compared with healthy controls though breast cancers did not show a significant change. SERPINA1 is an endogenous inhibitor of serine proteases and inhibits the catalytic domain of human recombinant matriptase in vitro. Rise in SERPINA1 occurs as an acute phase response to tissue necrosis and inflammation. mutations in SERPINA1 and SLC11A1 genes change the balance between elastase produced by leukocytes during phagocytosis. Alternative Name :
Alpha-1-antitrypsin; Alpha-1 protease inhibitor; Alpha-1-antiproteinase; Serpin A1; Short peptide from AAT; SPAAT; AAT; PI; ORF Names: PRO0684, PRO2209; α-1-antitrypsin; α-1 protease inhibitor; α-1-antiproteinase; α1-antitrypsin; α1 protease inhibitor; α1-antiproteinase; α1 antitrypsin; α1 antiproteinase Swiss-Prot :
P01009 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide SERPINA1. (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS5593 SERPINA1 pAb.
SERPINA1 Peptide Applications :
Blocking Background :
SERPINA1 is secreted and is a serine protease inhibitor which its targets include elastase, plasmin, collagenase, thrombin, leucocytic proteases, trypsin, chymotrypsin, and plasminogen activator. Defects in SERPINA1 gene can cause emphysema or liver disease. Antral SERPINA1 expression is particularly induced by H. pylori infection. lung and prostate cancers have shown a significant increase in SERPINA1 serum levels compared with healthy controls though breast cancers did not show a significant change. SERPINA1 is an endogenous inhibitor of serine proteases and inhibits the catalytic domain of human recombinant matriptase in vitro. Rise in SERPINA1 occurs as an acute phase response to tissue necrosis and inflammation. mutations in SERPINA1 and SLC11A1 genes change the balance between elastase produced by leukocytes during phagocytosis. Alternative Name :
Alpha-1-antitrypsin; Alpha-1 protease inhibitor; Alpha-1-antiproteinase; Serpin A1; Short peptide from AAT; SPAAT; AAT; PI; ORF Names: PRO0684, PRO2209; α-1-antitrypsin; α-1 protease inhibitor; α-1-antiproteinase; α1-antitrypsin; α1 protease inhibitor; α1-antiproteinase; α1 antitrypsin; α1 antiproteinase Swiss-Prot :
P01009 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide SERPINA1. (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS5593 SERPINA1 pAb.
Blocking peptide available as BS5593PP